The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase 1 study of AM003, a novel individualized immunotherapy, in a basket of advanced solid tumors.
 
Irit Carmi Levy
Employment - Aummune
Leadership - Aummune
Stock and Other Ownership Interests - Aummune
Patents, Royalties, Other Intellectual Property - Aummune
Travel, Accommodations, Expenses - Aummune
 
Leanne Amitzi
Employment - Aummune
Stock and Other Ownership Interests - Aummune
 
Erez Lavi
Employment - Aummune; Kamada (I)
Stock and Other Ownership Interests - Aummune
Patents, Royalties, Other Intellectual Property - Aummune
 
Neta Zilony - Hanin
Employment - Aummune; Teva (I)
Stock and Other Ownership Interests - Aummune
Patents, Royalties, Other Intellectual Property - Aummune
 
Zohar Pode
Employment - Aummune
Stock and Other Ownership Interests - Aummune; Protekt
Patents, Royalties, Other Intellectual Property - Aummune
 
Raanan Berger
Leadership - Aummune
Stock and Other Ownership Interests - Aummune; Belong; Curesponse; hopec; Pangea; PolyPid
Honoraria - Bristol-Myers Squibb; MSD
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Aummune; Belong; Bristol-Myers Squibb; Curesponse; Hopec; MSD; Pangea; PolyPid
 
Karen Smith
Leadership - Antares Pharmaceuticals; Aummune; Aurinia Pharmaceuticals; Sangamo Bioscience; Talaris
Stock and Other Ownership Interests - Antares Pharmaceuticals; Aurinia Pharmaceuticals; Quince; Sangamo Bioscience; Talaris
Consulting or Advisory Role - Aummune; Quince